-
公开(公告)号：EP1429742B1
公开(公告)日：2011-05-04
申请号：EP02766427.5
申请日：2002-09-28
申请人： McNeil-PPC, Inc.
发明人： LEE, Der-Yang , LI, Shun-Por , PARIKH, Narendra , MCTEIGUE, Dan , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
IPC分类号： A61K9/28
CPC分类号： A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要： In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
-
公开(公告)号：EP1429738B1
公开(公告)日：2007-10-31
申请号：EP02783988.5
申请日：2002-09-28
申请人： McNEIL-PPC, Inc.
发明人： LEE, Der-Yang , LI, Shun-Por , PARIKH, Narendra , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
IPC分类号： A61K9/20
CPC分类号： A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
-
公开(公告)号：EP1545472A1
公开(公告)日：2005-06-29
申请号：EP03798655.1
申请日：2003-03-21
申请人： McNeil-PPC, Inc.
IPC分类号： A61K9/20
CPC分类号： A61K9/284 , A61K9/0004 , A61K9/2072 , A61K9/2077 , A61K9/2095 , A61K9/2893
摘要： A modified release dosage form comprising at least one active ingredient and at least two cores surrounded by a shell is provided. The shell comprises at least one opening and provides for modified release of active ingredient upon contacting of the dosage form with a liquid medium. At least one of the cores is distal from the opening. In a preferred embodiment, the dosage form has a pulsatile release profile.
-
公开(公告)号：EP1429742A2
公开(公告)日：2004-06-23
申请号：EP02766427.5
申请日：2002-09-28
申请人： McNEIL-PPC, INC.
发明人： LEE, Der-Yang , LI, Shun-Por , PARIKH, Narendra , MCTEIGUE, Dan , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
IPC分类号： A61K9/28
CPC分类号： A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要： In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
-
-
-
搜索结果
14 条记录 (耗时 0.015 秒)
